nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—colon cancer	0.198	0.515	CiPCiCtD
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—colon cancer	0.186	0.485	CiPCiCtD
Gemcitabine—TYMS—colon cancer	0.106	0.798	CbGaD
Gemcitabine—breast cancer—colon cancer	0.0943	0.408	CtDrD
Gemcitabine—pancreatic cancer—colon cancer	0.0759	0.328	CtDrD
Gemcitabine—CDA—Capecitabine—colon cancer	0.0711	0.399	CbGbCtD
Gemcitabine—lung cancer—colon cancer	0.0613	0.265	CtDrD
Gemcitabine—TYMS—Capecitabine—colon cancer	0.0317	0.177	CbGbCtD
Gemcitabine—ABCB1—colon cancer	0.0269	0.202	CbGaD
Gemcitabine—SLC29A1—Fluorouracil—colon cancer	0.0203	0.114	CbGbCtD
Gemcitabine—TYMS—Fluorouracil—colon cancer	0.0188	0.105	CbGbCtD
Gemcitabine—ABCC10—Vincristine—colon cancer	0.0141	0.079	CbGbCtD
Gemcitabine—TYMS—Methotrexate—colon cancer	0.0103	0.058	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—colon cancer	0.00853	0.0478	CbGbCtD
Gemcitabine—ABCB1—Irinotecan—colon cancer	0.0015	0.00842	CbGbCtD
Gemcitabine—ABCB1—Vincristine—colon cancer	0.00131	0.00736	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—colon cancer	0.000795	0.00446	CbGbCtD
Gemcitabine—SLC28A1—renal system—colon cancer	0.000667	0.0364	CbGeAlD
Gemcitabine—SLC28A1—digestive system—colon cancer	0.000547	0.0299	CbGeAlD
Gemcitabine—POLD1—renal system—colon cancer	0.000444	0.0243	CbGeAlD
Gemcitabine—POLE—embryo—colon cancer	0.000439	0.024	CbGeAlD
Gemcitabine—SLC28A1—liver—colon cancer	0.000408	0.0223	CbGeAlD
Gemcitabine—POLD1—lymphoid tissue—colon cancer	0.000369	0.0201	CbGeAlD
Gemcitabine—CMPK1—smooth muscle tissue—colon cancer	0.000368	0.0201	CbGeAlD
Gemcitabine—POLD1—digestive system—colon cancer	0.000364	0.0199	CbGeAlD
Gemcitabine—RRM2—embryo—colon cancer	0.000361	0.0197	CbGeAlD
Gemcitabine—CMPK1—renal system—colon cancer	0.000354	0.0194	CbGeAlD
Gemcitabine—SLC28A3—digestive system—colon cancer	0.000334	0.0183	CbGeAlD
Gemcitabine—CDA—lymphoid tissue—colon cancer	0.000331	0.0181	CbGeAlD
Gemcitabine—SLC28A3—bone marrow—colon cancer	0.000308	0.0168	CbGeAlD
Gemcitabine—CDA—bone marrow—colon cancer	0.000301	0.0165	CbGeAlD
Gemcitabine—CMPK1—lymphoid tissue—colon cancer	0.000294	0.0161	CbGeAlD
Gemcitabine—CMPK1—digestive system—colon cancer	0.000291	0.0159	CbGeAlD
Gemcitabine—CDA—vagina—colon cancer	0.000289	0.0158	CbGeAlD
Gemcitabine—POLE—lymphoid tissue—colon cancer	0.000276	0.0151	CbGeAlD
Gemcitabine—DCK—Topotecan—Irinotecan—colon cancer	0.000274	0.32	CbGdCrCtD
Gemcitabine—RRM2—renal system—colon cancer	0.000273	0.0149	CbGeAlD
Gemcitabine—POLE—digestive system—colon cancer	0.000272	0.0149	CbGeAlD
Gemcitabine—POLD1—liver—colon cancer	0.000271	0.0148	CbGeAlD
Gemcitabine—SLC29A2—vagina—colon cancer	0.00027	0.0147	CbGeAlD
Gemcitabine—CMPK1—bone marrow—colon cancer	0.000268	0.0146	CbGeAlD
Gemcitabine—CMPK1—vagina—colon cancer	0.000257	0.014	CbGeAlD
Gemcitabine—POLE—bone marrow—colon cancer	0.000251	0.0137	CbGeAlD
Gemcitabine—CDA—liver—colon cancer	0.000244	0.0133	CbGeAlD
Gemcitabine—POLE—vagina—colon cancer	0.000241	0.0131	CbGeAlD
Gemcitabine—RRM1—smooth muscle tissue—colon cancer	0.000236	0.0129	CbGeAlD
Gemcitabine—DCK—embryo—colon cancer	0.000233	0.0127	CbGeAlD
Gemcitabine—SLC29A2—liver—colon cancer	0.000228	0.0124	CbGeAlD
Gemcitabine—RRM1—renal system—colon cancer	0.000227	0.0124	CbGeAlD
Gemcitabine—RRM2—lymphoid tissue—colon cancer	0.000227	0.0124	CbGeAlD
Gemcitabine—RRM2—digestive system—colon cancer	0.000224	0.0123	CbGeAlD
Gemcitabine—RRM2—Vinorelbine—Vincristine—colon cancer	0.000218	0.255	CbGdCrCtD
Gemcitabine—CMPK1—liver—colon cancer	0.000217	0.0118	CbGeAlD
Gemcitabine—POLA1—bone marrow—colon cancer	0.000216	0.0118	CbGeAlD
Gemcitabine—TYMS—smooth muscle tissue—colon cancer	0.000214	0.0117	CbGeAlD
Gemcitabine—POLD1—lymph node—colon cancer	0.000208	0.0114	CbGeAlD
Gemcitabine—POLA1—vagina—colon cancer	0.000207	0.0113	CbGeAlD
Gemcitabine—RRM2—bone marrow—colon cancer	0.000207	0.0113	CbGeAlD
Gemcitabine—POLA1—Vinblastine—Vincristine—colon cancer	0.000206	0.241	CbGdCrCtD
Gemcitabine—POLE—liver—colon cancer	0.000203	0.0111	CbGeAlD
Gemcitabine—RRM2—vagina—colon cancer	0.000198	0.0108	CbGeAlD
Gemcitabine—RRM1—lymphoid tissue—colon cancer	0.000189	0.0103	CbGeAlD
Gemcitabine—CDA—lymph node—colon cancer	0.000187	0.0102	CbGeAlD
Gemcitabine—RRM1—digestive system—colon cancer	0.000186	0.0102	CbGeAlD
Gemcitabine—SLC29A1—renal system—colon cancer	0.000185	0.0101	CbGeAlD
Gemcitabine—POLA1—liver—colon cancer	0.000175	0.00955	CbGeAlD
Gemcitabine—SLC29A2—lymph node—colon cancer	0.000175	0.00953	CbGeAlD
Gemcitabine—RRM1—bone marrow—colon cancer	0.000172	0.00938	CbGeAlD
Gemcitabine—TYMS—lymphoid tissue—colon cancer	0.000171	0.00934	CbGeAlD
Gemcitabine—TYMS—digestive system—colon cancer	0.000169	0.00923	CbGeAlD
Gemcitabine—ABCC10—renal system—colon cancer	0.000168	0.00918	CbGeAlD
Gemcitabine—RRM2—liver—colon cancer	0.000167	0.00913	CbGeAlD
Gemcitabine—CMPK1—lymph node—colon cancer	0.000166	0.00907	CbGeAlD
Gemcitabine—RRM1—vagina—colon cancer	0.000165	0.00899	CbGeAlD
Gemcitabine—TYMS—bone marrow—colon cancer	0.000156	0.00851	CbGeAlD
Gemcitabine—POLE—lymph node—colon cancer	0.000156	0.0085	CbGeAlD
Gemcitabine—SLC29A1—lymphoid tissue—colon cancer	0.000153	0.00838	CbGeAlD
Gemcitabine—SLC29A1—digestive system—colon cancer	0.000152	0.00828	CbGeAlD
Gemcitabine—TYMS—vagina—colon cancer	0.000149	0.00815	CbGeAlD
Gemcitabine—DCK—lymphoid tissue—colon cancer	0.000147	0.008	CbGeAlD
Gemcitabine—DCK—digestive system—colon cancer	0.000145	0.00791	CbGeAlD
Gemcitabine—SLC29A1—bone marrow—colon cancer	0.00014	0.00763	CbGeAlD
Gemcitabine—ABCC10—lymphoid tissue—colon cancer	0.00014	0.00763	CbGeAlD
Gemcitabine—RRM1—liver—colon cancer	0.000139	0.00758	CbGeAlD
Gemcitabine—ABCC10—digestive system—colon cancer	0.000138	0.00753	CbGeAlD
Gemcitabine—POLA1—lymph node—colon cancer	0.000134	0.00732	CbGeAlD
Gemcitabine—SLC29A1—vagina—colon cancer	0.000134	0.00731	CbGeAlD
Gemcitabine—DCK—bone marrow—colon cancer	0.000133	0.00729	CbGeAlD
Gemcitabine—RRM2—lymph node—colon cancer	0.000128	0.007	CbGeAlD
Gemcitabine—DCK—vagina—colon cancer	0.000128	0.00698	CbGeAlD
Gemcitabine—ABCC10—bone marrow—colon cancer	0.000127	0.00694	CbGeAlD
Gemcitabine—TYMS—liver—colon cancer	0.000126	0.00688	CbGeAlD
Gemcitabine—ABCC10—vagina—colon cancer	0.000122	0.00665	CbGeAlD
Gemcitabine—SLC29A1—liver—colon cancer	0.000113	0.00617	CbGeAlD
Gemcitabine—DCK—liver—colon cancer	0.000108	0.00589	CbGeAlD
Gemcitabine—ABCB1—blood vessel—colon cancer	0.000108	0.00587	CbGeAlD
Gemcitabine—RRM1—lymph node—colon cancer	0.000106	0.00581	CbGeAlD
Gemcitabine—ABCC10—liver—colon cancer	0.000103	0.00561	CbGeAlD
Gemcitabine—TYMS—lymph node—colon cancer	9.65e-05	0.00527	CbGeAlD
Gemcitabine—TYMS—Vinorelbine—Vincristine—colon cancer	9.32e-05	0.109	CbGdCrCtD
Gemcitabine—SLC29A1—lymph node—colon cancer	8.66e-05	0.00473	CbGeAlD
Gemcitabine—DCK—lymph node—colon cancer	8.27e-05	0.00452	CbGeAlD
Gemcitabine—ABCC10—lymph node—colon cancer	7.88e-05	0.0043	CbGeAlD
Gemcitabine—ABCB1—embryo—colon cancer	6.41e-05	0.0035	CbGeAlD
Gemcitabine—TYMS—Vinblastine—Vincristine—colon cancer	6.41e-05	0.0748	CbGdCrCtD
Gemcitabine—Angiopathy—Vincristine—colon cancer	5.92e-05	0.00215	CcSEcCtD
Gemcitabine—Cardiac disorder—Irinotecan—colon cancer	5.9e-05	0.00214	CcSEcCtD
Gemcitabine—Mediastinal disorder—Vincristine—colon cancer	5.88e-05	0.00214	CcSEcCtD
Gemcitabine—Alopecia—Vincristine—colon cancer	5.76e-05	0.00209	CcSEcCtD
Gemcitabine—Angiopathy—Irinotecan—colon cancer	5.76e-05	0.00209	CcSEcCtD
Gemcitabine—Blood creatinine increased—Capecitabine—colon cancer	5.76e-05	0.00209	CcSEcCtD
Gemcitabine—Immune system disorder—Irinotecan—colon cancer	5.74e-05	0.00208	CcSEcCtD
Gemcitabine—Mediastinal disorder—Irinotecan—colon cancer	5.72e-05	0.00208	CcSEcCtD
Gemcitabine—Chills—Irinotecan—colon cancer	5.7e-05	0.00207	CcSEcCtD
Gemcitabine—Arrhythmia—Irinotecan—colon cancer	5.67e-05	0.00206	CcSEcCtD
Gemcitabine—Liver function test abnormal—Capecitabine—colon cancer	5.67e-05	0.00206	CcSEcCtD
Gemcitabine—Alopecia—Irinotecan—colon cancer	5.61e-05	0.00204	CcSEcCtD
Gemcitabine—Pulmonary oedema—Methotrexate—colon cancer	5.61e-05	0.00204	CcSEcCtD
Gemcitabine—Hypokalaemia—Capecitabine—colon cancer	5.59e-05	0.00203	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Capecitabine—colon cancer	5.53e-05	0.00201	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Capecitabine—colon cancer	5.53e-05	0.00201	CcSEcCtD
Gemcitabine—Back pain—Vincristine—colon cancer	5.49e-05	0.002	CcSEcCtD
Gemcitabine—Sepsis—Methotrexate—colon cancer	5.47e-05	0.00199	CcSEcCtD
Gemcitabine—Arrhythmia—Fluorouracil—colon cancer	5.43e-05	0.00197	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Capecitabine—colon cancer	5.42e-05	0.00197	CcSEcCtD
Gemcitabine—Alopecia—Fluorouracil—colon cancer	5.38e-05	0.00195	CcSEcCtD
Gemcitabine—Back pain—Irinotecan—colon cancer	5.35e-05	0.00194	CcSEcCtD
Gemcitabine—Influenza—Capecitabine—colon cancer	5.31e-05	0.00193	CcSEcCtD
Gemcitabine—Erythema—Fluorouracil—colon cancer	5.3e-05	0.00192	CcSEcCtD
Gemcitabine—Anaemia—Vincristine—colon cancer	5.25e-05	0.00191	CcSEcCtD
Gemcitabine—ABCB1—epithelium—colon cancer	5.23e-05	0.00286	CbGeAlD
Gemcitabine—Bronchospasm—Capecitabine—colon cancer	5.22e-05	0.0019	CcSEcCtD
Gemcitabine—Ill-defined disorder—Irinotecan—colon cancer	5.13e-05	0.00186	CcSEcCtD
Gemcitabine—Anaemia—Irinotecan—colon cancer	5.11e-05	0.00186	CcSEcCtD
Gemcitabine—Hepatic failure—Methotrexate—colon cancer	5.09e-05	0.00185	CcSEcCtD
Gemcitabine—Leukopenia—Vincristine—colon cancer	5.08e-05	0.00185	CcSEcCtD
Gemcitabine—Pancytopenia—Capecitabine—colon cancer	5.04e-05	0.00183	CcSEcCtD
Gemcitabine—Malaise—Irinotecan—colon cancer	4.99e-05	0.00181	CcSEcCtD
Gemcitabine—Neutropenia—Capecitabine—colon cancer	4.97e-05	0.0018	CcSEcCtD
Gemcitabine—Leukopenia—Irinotecan—colon cancer	4.95e-05	0.0018	CcSEcCtD
Gemcitabine—Hypertension—Vincristine—colon cancer	4.9e-05	0.00178	CcSEcCtD
Gemcitabine—Anaemia—Fluorouracil—colon cancer	4.9e-05	0.00178	CcSEcCtD
Gemcitabine—ABCB1—renal system—colon cancer	4.85e-05	0.00265	CbGeAlD
Gemcitabine—Myalgia—Vincristine—colon cancer	4.83e-05	0.00176	CcSEcCtD
Gemcitabine—Cough—Irinotecan—colon cancer	4.83e-05	0.00175	CcSEcCtD
Gemcitabine—Hyperglycaemia—Capecitabine—colon cancer	4.79e-05	0.00174	CcSEcCtD
Gemcitabine—Hypertension—Irinotecan—colon cancer	4.77e-05	0.00173	CcSEcCtD
Gemcitabine—Pneumonia—Capecitabine—colon cancer	4.76e-05	0.00173	CcSEcCtD
Gemcitabine—Leukopenia—Fluorouracil—colon cancer	4.74e-05	0.00172	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Methotrexate—colon cancer	4.73e-05	0.00172	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Capecitabine—colon cancer	4.7e-05	0.00171	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Capecitabine—colon cancer	4.67e-05	0.0017	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Methotrexate—colon cancer	4.67e-05	0.0017	CcSEcCtD
Gemcitabine—Renal failure—Capecitabine—colon cancer	4.66e-05	0.00169	CcSEcCtD
Gemcitabine—Discomfort—Irinotecan—colon cancer	4.65e-05	0.00169	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Capecitabine—colon cancer	4.64e-05	0.00169	CcSEcCtD
Gemcitabine—Myocardial infarction—Capecitabine—colon cancer	4.64e-05	0.00169	CcSEcCtD
Gemcitabine—Anaphylactic shock—Vincristine—colon cancer	4.63e-05	0.00168	CcSEcCtD
Gemcitabine—Oedema—Vincristine—colon cancer	4.63e-05	0.00168	CcSEcCtD
Gemcitabine—Stomatitis—Capecitabine—colon cancer	4.62e-05	0.00168	CcSEcCtD
Gemcitabine—Infection—Vincristine—colon cancer	4.6e-05	0.00167	CcSEcCtD
Gemcitabine—Nervous system disorder—Vincristine—colon cancer	4.54e-05	0.00165	CcSEcCtD
Gemcitabine—Thrombocytopenia—Vincristine—colon cancer	4.54e-05	0.00165	CcSEcCtD
Gemcitabine—Haematuria—Capecitabine—colon cancer	4.52e-05	0.00164	CcSEcCtD
Gemcitabine—Oedema—Irinotecan—colon cancer	4.51e-05	0.00164	CcSEcCtD
Gemcitabine—Anaphylactic shock—Irinotecan—colon cancer	4.51e-05	0.00164	CcSEcCtD
Gemcitabine—Myalgia—Fluorouracil—colon cancer	4.51e-05	0.00164	CcSEcCtD
Gemcitabine—Chest pain—Fluorouracil—colon cancer	4.51e-05	0.00164	CcSEcCtD
Gemcitabine—Infection—Irinotecan—colon cancer	4.48e-05	0.00163	CcSEcCtD
Gemcitabine—Hyperhidrosis—Vincristine—colon cancer	4.48e-05	0.00163	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Capecitabine—colon cancer	4.48e-05	0.00163	CcSEcCtD
Gemcitabine—Discomfort—Fluorouracil—colon cancer	4.45e-05	0.00162	CcSEcCtD
Gemcitabine—Nervous system disorder—Irinotecan—colon cancer	4.43e-05	0.00161	CcSEcCtD
Gemcitabine—Agranulocytosis—Capecitabine—colon cancer	4.42e-05	0.00161	CcSEcCtD
Gemcitabine—Thrombocytopenia—Irinotecan—colon cancer	4.42e-05	0.00161	CcSEcCtD
Gemcitabine—Anorexia—Vincristine—colon cancer	4.42e-05	0.00161	CcSEcCtD
Gemcitabine—Hyperhidrosis—Irinotecan—colon cancer	4.36e-05	0.00159	CcSEcCtD
Gemcitabine—Hypotension—Vincristine—colon cancer	4.33e-05	0.00157	CcSEcCtD
Gemcitabine—Oedema—Fluorouracil—colon cancer	4.32e-05	0.00157	CcSEcCtD
Gemcitabine—Anaphylactic shock—Fluorouracil—colon cancer	4.32e-05	0.00157	CcSEcCtD
Gemcitabine—Anorexia—Irinotecan—colon cancer	4.3e-05	0.00156	CcSEcCtD
Gemcitabine—Infection—Fluorouracil—colon cancer	4.29e-05	0.00156	CcSEcCtD
Gemcitabine—Haemoglobin—Capecitabine—colon cancer	4.27e-05	0.00155	CcSEcCtD
Gemcitabine—Rhinitis—Capecitabine—colon cancer	4.26e-05	0.00155	CcSEcCtD
Gemcitabine—Haemorrhage—Capecitabine—colon cancer	4.25e-05	0.00154	CcSEcCtD
Gemcitabine—Nervous system disorder—Fluorouracil—colon cancer	4.24e-05	0.00154	CcSEcCtD
Gemcitabine—Thrombocytopenia—Fluorouracil—colon cancer	4.23e-05	0.00154	CcSEcCtD
Gemcitabine—Liver function test abnormal—Methotrexate—colon cancer	4.22e-05	0.00153	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Vincristine—colon cancer	4.22e-05	0.00153	CcSEcCtD
Gemcitabine—Pharyngitis—Capecitabine—colon cancer	4.22e-05	0.00153	CcSEcCtD
Gemcitabine—Hypotension—Irinotecan—colon cancer	4.22e-05	0.00153	CcSEcCtD
Gemcitabine—Urinary tract disorder—Capecitabine—colon cancer	4.2e-05	0.00153	CcSEcCtD
Gemcitabine—Insomnia—Vincristine—colon cancer	4.19e-05	0.00152	CcSEcCtD
Gemcitabine—Oedema peripheral—Capecitabine—colon cancer	4.19e-05	0.00152	CcSEcCtD
Gemcitabine—Connective tissue disorder—Capecitabine—colon cancer	4.18e-05	0.00152	CcSEcCtD
Gemcitabine—Urethral disorder—Capecitabine—colon cancer	4.17e-05	0.00151	CcSEcCtD
Gemcitabine—Paraesthesia—Vincristine—colon cancer	4.16e-05	0.00151	CcSEcCtD
Gemcitabine—Anorexia—Fluorouracil—colon cancer	4.12e-05	0.0015	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Methotrexate—colon cancer	4.12e-05	0.0015	CcSEcCtD
Gemcitabine—Insomnia—Irinotecan—colon cancer	4.08e-05	0.00148	CcSEcCtD
Gemcitabine—Paraesthesia—Irinotecan—colon cancer	4.05e-05	0.00147	CcSEcCtD
Gemcitabine—Hypotension—Fluorouracil—colon cancer	4.04e-05	0.00147	CcSEcCtD
Gemcitabine—ABCB1—lymphoid tissue—colon cancer	4.03e-05	0.0022	CbGeAlD
Gemcitabine—Decreased appetite—Vincristine—colon cancer	4.03e-05	0.00146	CcSEcCtD
Gemcitabine—Dyspnoea—Irinotecan—colon cancer	4.02e-05	0.00146	CcSEcCtD
Gemcitabine—Erythema multiforme—Capecitabine—colon cancer	4.02e-05	0.00146	CcSEcCtD
Gemcitabine—Somnolence—Irinotecan—colon cancer	4.01e-05	0.00146	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Vincristine—colon cancer	4e-05	0.00145	CcSEcCtD
Gemcitabine—Fatigue—Vincristine—colon cancer	4e-05	0.00145	CcSEcCtD
Gemcitabine—ABCB1—digestive system—colon cancer	3.98e-05	0.00217	CbGeAlD
Gemcitabine—Pain—Vincristine—colon cancer	3.96e-05	0.00144	CcSEcCtD
Gemcitabine—Constipation—Vincristine—colon cancer	3.96e-05	0.00144	CcSEcCtD
Gemcitabine—Cardiac disorder—Capecitabine—colon cancer	3.95e-05	0.00143	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Fluorouracil—colon cancer	3.94e-05	0.00143	CcSEcCtD
Gemcitabine—Decreased appetite—Irinotecan—colon cancer	3.92e-05	0.00143	CcSEcCtD
Gemcitabine—Insomnia—Fluorouracil—colon cancer	3.91e-05	0.00142	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Irinotecan—colon cancer	3.9e-05	0.00142	CcSEcCtD
Gemcitabine—Fatigue—Irinotecan—colon cancer	3.89e-05	0.00141	CcSEcCtD
Gemcitabine—Paraesthesia—Fluorouracil—colon cancer	3.88e-05	0.00141	CcSEcCtD
Gemcitabine—Pain—Irinotecan—colon cancer	3.86e-05	0.0014	CcSEcCtD
Gemcitabine—Constipation—Irinotecan—colon cancer	3.86e-05	0.0014	CcSEcCtD
Gemcitabine—Angiopathy—Capecitabine—colon cancer	3.86e-05	0.0014	CcSEcCtD
Gemcitabine—Dyspnoea—Fluorouracil—colon cancer	3.85e-05	0.0014	CcSEcCtD
Gemcitabine—Somnolence—Fluorouracil—colon cancer	3.84e-05	0.0014	CcSEcCtD
Gemcitabine—Immune system disorder—Capecitabine—colon cancer	3.84e-05	0.0014	CcSEcCtD
Gemcitabine—Mediastinal disorder—Capecitabine—colon cancer	3.83e-05	0.00139	CcSEcCtD
Gemcitabine—Chills—Capecitabine—colon cancer	3.81e-05	0.00139	CcSEcCtD
Gemcitabine—Arrhythmia—Capecitabine—colon cancer	3.8e-05	0.00138	CcSEcCtD
Gemcitabine—Decreased appetite—Fluorouracil—colon cancer	3.76e-05	0.00137	CcSEcCtD
Gemcitabine—Alopecia—Capecitabine—colon cancer	3.76e-05	0.00137	CcSEcCtD
Gemcitabine—Pancytopenia—Methotrexate—colon cancer	3.76e-05	0.00136	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Fluorouracil—colon cancer	3.73e-05	0.00136	CcSEcCtD
Gemcitabine—Feeling abnormal—Irinotecan—colon cancer	3.72e-05	0.00135	CcSEcCtD
Gemcitabine—Erythema—Capecitabine—colon cancer	3.7e-05	0.00134	CcSEcCtD
Gemcitabine—Neutropenia—Methotrexate—colon cancer	3.7e-05	0.00134	CcSEcCtD
Gemcitabine—Pain—Fluorouracil—colon cancer	3.7e-05	0.00134	CcSEcCtD
Gemcitabine—ABCB1—bone marrow—colon cancer	3.67e-05	0.002	CbGeAlD
Gemcitabine—Body temperature increased—Vincristine—colon cancer	3.66e-05	0.00133	CcSEcCtD
Gemcitabine—Back pain—Capecitabine—colon cancer	3.58e-05	0.0013	CcSEcCtD
Gemcitabine—Body temperature increased—Irinotecan—colon cancer	3.57e-05	0.0013	CcSEcCtD
Gemcitabine—Feeling abnormal—Fluorouracil—colon cancer	3.56e-05	0.00129	CcSEcCtD
Gemcitabine—Pneumonia—Methotrexate—colon cancer	3.55e-05	0.00129	CcSEcCtD
Gemcitabine—ABCB1—vagina—colon cancer	3.52e-05	0.00192	CbGeAlD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—colon cancer	3.5e-05	0.00127	CcSEcCtD
Gemcitabine—Renal failure—Methotrexate—colon cancer	3.47e-05	0.00126	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—colon cancer	3.44e-05	0.00125	CcSEcCtD
Gemcitabine—Ill-defined disorder—Capecitabine—colon cancer	3.43e-05	0.00125	CcSEcCtD
Gemcitabine—Anaemia—Capecitabine—colon cancer	3.42e-05	0.00124	CcSEcCtD
Gemcitabine—Body temperature increased—Fluorouracil—colon cancer	3.42e-05	0.00124	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—colon cancer	3.38e-05	0.00123	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—colon cancer	3.36e-05	0.00122	CcSEcCtD
Gemcitabine—Malaise—Capecitabine—colon cancer	3.34e-05	0.00121	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—colon cancer	3.33e-05	0.00121	CcSEcCtD
Gemcitabine—Asthenia—Vincristine—colon cancer	3.32e-05	0.00121	CcSEcCtD
Gemcitabine—Leukopenia—Capecitabine—colon cancer	3.31e-05	0.0012	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—colon cancer	3.29e-05	0.0012	CcSEcCtD
Gemcitabine—Asthenia—Irinotecan—colon cancer	3.24e-05	0.00118	CcSEcCtD
Gemcitabine—Cough—Capecitabine—colon cancer	3.23e-05	0.00117	CcSEcCtD
Gemcitabine—Hypertension—Capecitabine—colon cancer	3.2e-05	0.00116	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—colon cancer	3.18e-05	0.00116	CcSEcCtD
Gemcitabine—Diarrhoea—Vincristine—colon cancer	3.17e-05	0.00115	CcSEcCtD
Gemcitabine—Haemorrhage—Methotrexate—colon cancer	3.16e-05	0.00115	CcSEcCtD
Gemcitabine—Arthralgia—Capecitabine—colon cancer	3.15e-05	0.00114	CcSEcCtD
Gemcitabine—Chest pain—Capecitabine—colon cancer	3.15e-05	0.00114	CcSEcCtD
Gemcitabine—Myalgia—Capecitabine—colon cancer	3.15e-05	0.00114	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—colon cancer	3.14e-05	0.00114	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	3.13e-05	0.00114	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—colon cancer	3.13e-05	0.00114	CcSEcCtD
Gemcitabine—Discomfort—Capecitabine—colon cancer	3.11e-05	0.00113	CcSEcCtD
Gemcitabine—Urethral disorder—Methotrexate—colon cancer	3.1e-05	0.00113	CcSEcCtD
Gemcitabine—Diarrhoea—Irinotecan—colon cancer	3.09e-05	0.00112	CcSEcCtD
Gemcitabine—Pruritus—Fluorouracil—colon cancer	3.06e-05	0.00111	CcSEcCtD
Gemcitabine—Oedema—Capecitabine—colon cancer	3.02e-05	0.0011	CcSEcCtD
Gemcitabine—Infection—Capecitabine—colon cancer	3e-05	0.00109	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—colon cancer	2.99e-05	0.00109	CcSEcCtD
Gemcitabine—ABCB1—liver—colon cancer	2.97e-05	0.00162	CbGeAlD
Gemcitabine—Nervous system disorder—Capecitabine—colon cancer	2.96e-05	0.00108	CcSEcCtD
Gemcitabine—Diarrhoea—Fluorouracil—colon cancer	2.96e-05	0.00107	CcSEcCtD
Gemcitabine—Thrombocytopenia—Capecitabine—colon cancer	2.96e-05	0.00107	CcSEcCtD
Gemcitabine—Vomiting—Vincristine—colon cancer	2.95e-05	0.00107	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—colon cancer	2.94e-05	0.00107	CcSEcCtD
Gemcitabine—Skin disorder—Capecitabine—colon cancer	2.93e-05	0.00107	CcSEcCtD
Gemcitabine—Rash—Vincristine—colon cancer	2.92e-05	0.00106	CcSEcCtD
Gemcitabine—Hyperhidrosis—Capecitabine—colon cancer	2.92e-05	0.00106	CcSEcCtD
Gemcitabine—Dermatitis—Vincristine—colon cancer	2.92e-05	0.00106	CcSEcCtD
Gemcitabine—Headache—Vincristine—colon cancer	2.9e-05	0.00105	CcSEcCtD
Gemcitabine—Anorexia—Capecitabine—colon cancer	2.88e-05	0.00105	CcSEcCtD
Gemcitabine—Angiopathy—Methotrexate—colon cancer	2.87e-05	0.00104	CcSEcCtD
Gemcitabine—Vomiting—Irinotecan—colon cancer	2.87e-05	0.00104	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—colon cancer	2.86e-05	0.00104	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—colon cancer	2.85e-05	0.00104	CcSEcCtD
Gemcitabine—Rash—Irinotecan—colon cancer	2.85e-05	0.00103	CcSEcCtD
Gemcitabine—Dermatitis—Irinotecan—colon cancer	2.84e-05	0.00103	CcSEcCtD
Gemcitabine—Chills—Methotrexate—colon cancer	2.84e-05	0.00103	CcSEcCtD
Gemcitabine—Headache—Irinotecan—colon cancer	2.83e-05	0.00103	CcSEcCtD
Gemcitabine—Hypotension—Capecitabine—colon cancer	2.82e-05	0.00103	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—colon cancer	2.8e-05	0.00102	CcSEcCtD
Gemcitabine—Erythema—Methotrexate—colon cancer	2.76e-05	0.001	CcSEcCtD
Gemcitabine—Nausea—Vincristine—colon cancer	2.75e-05	0.001	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Capecitabine—colon cancer	2.75e-05	0.001	CcSEcCtD
Gemcitabine—Vomiting—Fluorouracil—colon cancer	2.75e-05	0.000999	CcSEcCtD
Gemcitabine—Insomnia—Capecitabine—colon cancer	2.73e-05	0.000993	CcSEcCtD
Gemcitabine—Rash—Fluorouracil—colon cancer	2.73e-05	0.00099	CcSEcCtD
Gemcitabine—Dermatitis—Fluorouracil—colon cancer	2.72e-05	0.000989	CcSEcCtD
Gemcitabine—Paraesthesia—Capecitabine—colon cancer	2.71e-05	0.000985	CcSEcCtD
Gemcitabine—Headache—Fluorouracil—colon cancer	2.71e-05	0.000984	CcSEcCtD
Gemcitabine—Dyspnoea—Capecitabine—colon cancer	2.69e-05	0.000978	CcSEcCtD
Gemcitabine—Nausea—Irinotecan—colon cancer	2.68e-05	0.000974	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—colon cancer	2.66e-05	0.000968	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—MLH1—colon cancer	2.64e-05	0.00101	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.64e-05	0.00101	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—EP300—colon cancer	2.63e-05	0.001	CbGpPWpGaD
Gemcitabine—Decreased appetite—Capecitabine—colon cancer	2.63e-05	0.000954	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Capecitabine—colon cancer	2.61e-05	0.000948	CcSEcCtD
Gemcitabine—Fatigue—Capecitabine—colon cancer	2.6e-05	0.000946	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.59e-05	0.000992	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	2.59e-05	0.00099	CbGpPWpGaD
Gemcitabine—Pain—Capecitabine—colon cancer	2.58e-05	0.000939	CcSEcCtD
Gemcitabine—Constipation—Capecitabine—colon cancer	2.58e-05	0.000939	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN1A—colon cancer	2.58e-05	0.000985	CbGpPWpGaD
Gemcitabine—Nausea—Fluorouracil—colon cancer	2.57e-05	0.000933	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—colon cancer	2.56e-05	0.000929	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CCND1—colon cancer	2.56e-05	0.000977	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MLH1—colon cancer	2.55e-05	0.000976	CbGpPWpGaD
Gemcitabine—Anaemia—Methotrexate—colon cancer	2.55e-05	0.000925	CcSEcCtD
Gemcitabine—RRM2—G1/S Transition—MYC—colon cancer	2.53e-05	0.000969	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—BUB1B—colon cancer	2.53e-05	0.000967	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.53e-05	0.000967	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.52e-05	0.000962	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—BUB1B—colon cancer	2.51e-05	0.000961	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	2.5e-05	0.000957	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—colon cancer	2.49e-05	0.000953	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Capecitabine—colon cancer	2.49e-05	0.000904	CcSEcCtD
Gemcitabine—Malaise—Methotrexate—colon cancer	2.48e-05	0.000903	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	2.48e-05	0.000948	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN1A—colon cancer	2.47e-05	0.000945	CbGpPWpGaD
Gemcitabine—Leukopenia—Methotrexate—colon cancer	2.47e-05	0.000896	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.45e-05	0.000937	CbGpPWpGaD
Gemcitabine—POLE—G1/S Transition—MYC—colon cancer	2.43e-05	0.00093	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—BUB1B—colon cancer	2.43e-05	0.000928	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.43e-05	0.000928	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ABCB1—colon cancer	2.41e-05	0.000923	CbGpPWpGaD
Gemcitabine—Cough—Methotrexate—colon cancer	2.4e-05	0.000874	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	2.4e-05	0.000917	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—colon cancer	2.39e-05	0.000915	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—MYC—colon cancer	2.39e-05	0.000913	CbGpPWpGaD
Gemcitabine—Body temperature increased—Capecitabine—colon cancer	2.39e-05	0.000868	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.37e-05	0.000906	CbGpPWpGaD
Gemcitabine—Myalgia—Methotrexate—colon cancer	2.35e-05	0.000852	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—colon cancer	2.35e-05	0.000852	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—colon cancer	2.35e-05	0.000852	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	2.33e-05	0.000846	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—colon cancer	2.33e-05	0.000891	CbGpPWpGaD
Gemcitabine—Discomfort—Methotrexate—colon cancer	2.32e-05	0.000842	CcSEcCtD
Gemcitabine—POLA1—Synthesis of DNA—CDKN1A—colon cancer	2.31e-05	0.000885	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—BUB1B—colon cancer	2.31e-05	0.000885	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	2.3e-05	0.00088	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—MYC—colon cancer	2.29e-05	0.000875	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—MYC—colon cancer	2.29e-05	0.000874	CbGpPWpGaD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.28e-05	0.000873	CbGpPWpGaD
Gemcitabine—ABCB1—lymph node—colon cancer	2.27e-05	0.00124	CbGeAlD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ABCB1—colon cancer	2.27e-05	0.000867	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—BUB1B—colon cancer	2.26e-05	0.000865	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.25e-05	0.000862	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Methotrexate—colon cancer	2.25e-05	0.000817	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—BUB1B—colon cancer	2.25e-05	0.00086	CbGpPWpGaD
Gemcitabine—Infection—Methotrexate—colon cancer	2.23e-05	0.000812	CcSEcCtD
Gemcitabine—POLE—S Phase—MYC—colon cancer	2.21e-05	0.000845	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Methotrexate—colon cancer	2.21e-05	0.000801	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—colon cancer	2.2e-05	0.0008	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.19e-05	0.000838	CbGpPWpGaD
Gemcitabine—Skin disorder—Methotrexate—colon cancer	2.18e-05	0.000794	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methotrexate—colon cancer	2.17e-05	0.00079	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—BUB1B—colon cancer	2.17e-05	0.00083	CbGpPWpGaD
Gemcitabine—POLA1—DNA Replication—CDKN1A—colon cancer	2.17e-05	0.00083	CbGpPWpGaD
Gemcitabine—Asthenia—Capecitabine—colon cancer	2.17e-05	0.000787	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—colon cancer	2.14e-05	0.000779	CcSEcCtD
Gemcitabine—Pruritus—Capecitabine—colon cancer	2.14e-05	0.000776	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—MYC—colon cancer	2.14e-05	0.000817	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.14e-05	0.000817	CbGpPWpGaD
Gemcitabine—Hypotension—Methotrexate—colon cancer	2.1e-05	0.000763	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—CDKN1A—colon cancer	2.09e-05	0.000799	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—colon cancer	2.08e-05	0.000794	CbGpPWpGaD
Gemcitabine—Diarrhoea—Capecitabine—colon cancer	2.07e-05	0.000751	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—MYC—colon cancer	2.05e-05	0.000784	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—colon cancer	2.05e-05	0.000744	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—colon cancer	2.03e-05	0.000739	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—colon cancer	2.02e-05	0.000734	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.01e-05	0.000769	CbGpPWpGaD
Gemcitabine—Dyspnoea—Methotrexate—colon cancer	2e-05	0.000728	CcSEcCtD
Gemcitabine—TYMS—G1/S Transition—CDKN1A—colon cancer	2e-05	0.000766	CbGpPWpGaD
Gemcitabine—Somnolence—Methotrexate—colon cancer	2e-05	0.000726	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—colon cancer	1.99e-05	0.000761	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ABCB1—colon cancer	1.97e-05	0.000752	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.96e-05	0.000751	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—CCND1—colon cancer	1.96e-05	0.00075	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.96e-05	0.000749	CbGpPWpGaD
Gemcitabine—Decreased appetite—Methotrexate—colon cancer	1.95e-05	0.00071	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—colon cancer	1.94e-05	0.000705	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—TYMS—colon cancer	1.94e-05	0.000742	CbGpPWpGaD
Gemcitabine—Fatigue—Methotrexate—colon cancer	1.94e-05	0.000704	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—TYMS—colon cancer	1.93e-05	0.000739	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—TYMS—colon cancer	1.93e-05	0.000737	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.93e-05	0.000737	CbGpPWpGaD
Gemcitabine—Pain—Methotrexate—colon cancer	1.92e-05	0.000699	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.92e-05	0.000735	CbGpPWpGaD
Gemcitabine—Vomiting—Capecitabine—colon cancer	1.92e-05	0.000698	CcSEcCtD
Gemcitabine—Rash—Capecitabine—colon cancer	1.9e-05	0.000692	CcSEcCtD
Gemcitabine—Dermatitis—Capecitabine—colon cancer	1.9e-05	0.000691	CcSEcCtD
Gemcitabine—POLA1—S Phase—CDKN1A—colon cancer	1.9e-05	0.000726	CbGpPWpGaD
Gemcitabine—Headache—Capecitabine—colon cancer	1.89e-05	0.000688	CcSEcCtD
Gemcitabine—TYMS—Metabolism—CHST5—colon cancer	1.88e-05	0.000719	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ODC1—colon cancer	1.88e-05	0.000719	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—TYMS—colon cancer	1.86e-05	0.000712	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Methotrexate—colon cancer	1.85e-05	0.000673	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CCND1—colon cancer	1.82e-05	0.000696	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MLH1—colon cancer	1.82e-05	0.000696	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.82e-05	0.000694	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.8e-05	0.000688	CbGpPWpGaD
Gemcitabine—Nausea—Capecitabine—colon cancer	1.79e-05	0.000652	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—PPARG—colon cancer	1.78e-05	0.000683	CbGpPWpGaD
Gemcitabine—Body temperature increased—Methotrexate—colon cancer	1.78e-05	0.000646	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—colon cancer	1.76e-05	0.000674	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CCND1—colon cancer	1.74e-05	0.000667	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MLH1—colon cancer	1.74e-05	0.000667	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TYMS—colon cancer	1.73e-05	0.000663	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—MYC—colon cancer	1.73e-05	0.000663	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—BUB1B—colon cancer	1.73e-05	0.000662	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TYMS—colon cancer	1.72e-05	0.000659	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—colon cancer	1.7e-05	0.000652	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN1A—colon cancer	1.69e-05	0.000645	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.67e-05	0.000638	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TYMS—colon cancer	1.66e-05	0.000637	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—MYC—colon cancer	1.66e-05	0.000635	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—BUB1B—colon cancer	1.66e-05	0.000634	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—colon cancer	1.63e-05	0.000625	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.61e-05	0.000617	CbGpPWpGaD
Gemcitabine—Asthenia—Methotrexate—colon cancer	1.61e-05	0.000586	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—colon cancer	1.59e-05	0.000578	CcSEcCtD
Gemcitabine—POLA1—S Phase—MYC—colon cancer	1.57e-05	0.000602	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	1.57e-05	0.0006	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BUB1B—colon cancer	1.55e-05	0.000592	CbGpPWpGaD
Gemcitabine—Diarrhoea—Methotrexate—colon cancer	1.54e-05	0.000559	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.53e-05	0.000584	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BUB1B—colon cancer	1.48e-05	0.000567	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.46e-05	0.000559	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—MYC—colon cancer	1.46e-05	0.000559	CbGpPWpGaD
Gemcitabine—Vomiting—Methotrexate—colon cancer	1.43e-05	0.000519	CcSEcCtD
Gemcitabine—Rash—Methotrexate—colon cancer	1.42e-05	0.000515	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.42e-05	0.000542	CbGpPWpGaD
Gemcitabine—Dermatitis—Methotrexate—colon cancer	1.42e-05	0.000515	CcSEcCtD
Gemcitabine—Headache—Methotrexate—colon cancer	1.41e-05	0.000512	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—colon cancer	1.4e-05	0.000535	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.38e-05	0.000528	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PPARG—colon cancer	1.37e-05	0.000523	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.37e-05	0.000522	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.36e-05	0.000521	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.36e-05	0.000519	CbGpPWpGaD
Gemcitabine—Nausea—Methotrexate—colon cancer	1.34e-05	0.000485	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.33e-05	0.00051	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—TYMS—colon cancer	1.33e-05	0.000507	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.32e-05	0.000505	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	1.32e-05	0.000505	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.31e-05	0.000501	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.28e-05	0.000489	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.27e-05	0.000486	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.23e-05	0.000472	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.22e-05	0.000465	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ABCB1—colon cancer	1.22e-05	0.000465	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.2e-05	0.00046	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—TYMS—colon cancer	1.19e-05	0.000456	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TYMS—colon cancer	1.19e-05	0.000454	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.18e-05	0.000452	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—EP300—colon cancer	1.17e-05	0.000447	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.15e-05	0.000441	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.11e-05	0.000423	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.1e-05	0.000422	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.08e-05	0.000414	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—colon cancer	1.08e-05	0.000412	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.06e-05	0.000405	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.06e-05	0.000404	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	1.06e-05	0.000404	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.04e-05	0.000397	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.02e-05	0.000391	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	9.79e-06	0.000375	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—colon cancer	9.76e-06	0.000373	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	9.71e-06	0.000371	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—colon cancer	9.7e-06	0.000371	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA7—colon cancer	9.58e-06	0.000366	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1A—colon cancer	9.45e-06	0.000361	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.39e-06	0.000359	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1A—colon cancer	9.39e-06	0.000359	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—colon cancer	9.37e-06	0.000358	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ABCB1—colon cancer	9.21e-06	0.000352	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.09e-06	0.000348	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1A—colon cancer	9.07e-06	0.000347	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TYMS—colon cancer	9.05e-06	0.000346	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9e-06	0.000344	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—EP300—colon cancer	8.99e-06	0.000344	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—EP300—colon cancer	8.95e-06	0.000342	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—EP300—colon cancer	8.93e-06	0.000342	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	8.78e-06	0.000336	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—colon cancer	8.73e-06	0.000334	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	8.71e-06	0.000333	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—colon cancer	8.68e-06	0.000332	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—EP300—colon cancer	8.63e-06	0.00033	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP3—colon cancer	8.49e-06	0.000325	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—colon cancer	8.46e-06	0.000323	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1A—colon cancer	8.45e-06	0.000323	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1A—colon cancer	8.39e-06	0.000321	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—colon cancer	8.38e-06	0.00032	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—colon cancer	8.36e-06	0.00032	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	8.32e-06	0.000318	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1A—colon cancer	8.11e-06	0.00031	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	8.1e-06	0.00031	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—EP300—colon cancer	8.04e-06	0.000307	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—EP300—colon cancer	7.99e-06	0.000305	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—colon cancer	7.83e-06	0.0003	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	7.8e-06	0.000298	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—colon cancer	7.78e-06	0.000298	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—EP300—colon cancer	7.71e-06	0.000295	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.67e-06	0.000293	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ABCB1—colon cancer	7.58e-06	0.00029	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ABCB1—colon cancer	7.54e-06	0.000288	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—colon cancer	7.52e-06	0.000288	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TYMS—colon cancer	7.45e-06	0.000285	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TYMS—colon cancer	7.4e-06	0.000283	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.35e-06	0.000281	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—colon cancer	7.2e-06	0.000276	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCB1—colon cancer	7.09e-06	0.000271	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—colon cancer	7e-06	0.000268	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TYMS—colon cancer	6.96e-06	0.000266	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—colon cancer	6.96e-06	0.000266	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—colon cancer	6.72e-06	0.000257	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—colon cancer	6.68e-06	0.000255	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—colon cancer	6.65e-06	0.000254	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—colon cancer	6.62e-06	0.000253	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—colon cancer	6.61e-06	0.000253	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—colon cancer	6.46e-06	0.000247	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—colon cancer	6.41e-06	0.000245	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—colon cancer	6.4e-06	0.000245	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—colon cancer	6.19e-06	0.000237	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—EP300—colon cancer	6.15e-06	0.000235	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—colon cancer	5.97e-06	0.000228	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	5.94e-06	0.000227	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—EP300—colon cancer	5.89e-06	0.000225	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CHST5—colon cancer	5.8e-06	0.000222	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ODC1—colon cancer	5.8e-06	0.000222	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—colon cancer	5.78e-06	0.000221	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—colon cancer	5.75e-06	0.00022	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—colon cancer	5.72e-06	0.000219	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—colon cancer	5.72e-06	0.000219	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—colon cancer	5.53e-06	0.000212	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—EP300—colon cancer	5.53e-06	0.000212	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—colon cancer	5.52e-06	0.000211	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—EP300—colon cancer	5.5e-06	0.00021	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—colon cancer	5.41e-06	0.000207	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—colon cancer	5.36e-06	0.000205	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	5.31e-06	0.000203	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—colon cancer	5.28e-06	0.000202	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—EP300—colon cancer	5.27e-06	0.000201	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—colon cancer	5.24e-06	0.000201	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—colon cancer	5.13e-06	0.000196	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—colon cancer	5.04e-06	0.000193	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCB1—colon cancer	4.97e-06	0.00019	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—colon cancer	4.93e-06	0.000189	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—colon cancer	4.79e-06	0.000183	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—colon cancer	4.59e-06	0.000175	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	4.51e-06	0.000173	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—EP300—colon cancer	4.19e-06	0.00016	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	4.19e-06	0.00016	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—colon cancer	4.15e-06	0.000159	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—colon cancer	4.13e-06	0.000158	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—colon cancer	4.09e-06	0.000157	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	4.08e-06	0.000156	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	4.04e-06	0.000154	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	3.94e-06	0.000151	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—colon cancer	3.93e-06	0.00015	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—colon cancer	3.88e-06	0.000148	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—colon cancer	3.77e-06	0.000144	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	3.75e-06	0.000144	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	3.65e-06	0.00014	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	3.55e-06	0.000136	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—colon cancer	3.46e-06	0.000132	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—EP300—colon cancer	3.45e-06	0.000132	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—EP300—colon cancer	3.43e-06	0.000131	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—colon cancer	3.34e-06	0.000128	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	3.27e-06	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	3.26e-06	0.000125	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—EP300—colon cancer	3.23e-06	0.000123	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	3.2e-06	0.000122	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—colon cancer	3.1e-06	0.000119	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.02e-06	0.000116	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.78e-06	0.000106	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—colon cancer	2.72e-06	0.000104	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.69e-06	0.000103	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—colon cancer	2.55e-06	9.77e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—colon cancer	2.54e-06	9.71e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—colon cancer	2.53e-06	9.69e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—colon cancer	2.39e-06	9.13e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.27e-06	8.67e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—EP300—colon cancer	2.26e-06	8.65e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—colon cancer	2.09e-06	7.98e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—colon cancer	2.07e-06	7.93e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—colon cancer	1.95e-06	7.46e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—colon cancer	1.67e-06	6.4e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMS—colon cancer	1.51e-06	5.76e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—colon cancer	1.37e-06	5.23e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—colon cancer	1.07e-06	4.08e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—colon cancer	8.39e-07	3.21e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EP300—colon cancer	6.98e-07	2.67e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—colon cancer	5.16e-07	1.97e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—colon cancer	4.22e-07	1.61e-05	CbGpPWpGaD
